Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UPSIDE Foods was the first company globally to develop cell-cultured beef and poultry products. It received the first FDA "no questions" letter on safety for its cultivated chicken process in November 2022 and USDA label approval in June 2023. The company has opened large-scale pilot facilities but faces technical challenges scaling up bioreactor output. Its products are not yet widely available commercially as of mid–2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UPSIDE Foods.